Your session is about to expire
← Back to Search
SY-201 Ophthalmic Solution 2.0% for Dry Eye Syndrome
Study Summary
This trial is testing a new eye drop for people with dry eye disease to see if it is safe, tolerated, and effective.
- Dry Eye Syndrome
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this research experiment recruiting volunteers at present?
"Clinicaltrials.gov reveals that this research initiative is still in need of participants, having first been posted on July 25th 2022 and amended a mere two days later."
Is the patient demographic for this study exclusive to those over seventy years old?
"This trial will accept patients that are aged between 18 and 99. Additionally, there exists 15 clinical trials for youths under the age of majority as well as 124 studies catered to those above senior citizens' age."
To what extent has participation been achieved in this medical experiment?
"Affirmative. Clinicaltrials.gov's records show that this experiment, which was first shared on July 25th 2022 is actively looking for participants. 200 volunteers are required from a single medical facility."
Could I possibly be enrolled in this medical experiment?
"This medical trial is enrolling 200 adults aged 18-99 with dry eye syndrome. Key prerequisites include providing written consent, having a minimum BCVA of +0.7 LogMAR or better as assessed by the ETDRS at Visit 1., and being able to attend all required visits for study duration."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger